Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 48001 [2024-12103]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 108 / Tuesday, June 4, 2024 / Notices
Owner, LLC., a wholly owned
subsidiary of TerraPower, filed an
application for a construction permit for
a single-unit power reactor facility
located in Lincoln County, Wyoming,
pursuant to section 103 of the Atomic
Energy Act, as amended, and part 50 of
title 10 of the Code of Federal
Regulations (10 CFR), ‘‘Domestic
Licensing of Production and Utilization
Facilities.’’ The single-unit facility is to
be identified as Kemmerer Power
Station, Unit 1 and would be based on
the TerraPower and General ElectricHitachi Natrium reactor design which is
a pool-type sodium fast reactor using
metal fuel.
The application submitted on March
28, 2024, is available in ADAMS under
Package Accession No. ML24088A059.
Along with other documents, the
ADAMS package includes the
transmittal letter (ADAMS Accession
No. ML24088A060), the preliminary
safety analysis report (ADAMS
Accession No. ML24088A065), and the
environmental report (ADAMS
Accession No. ML24088A072). The
application was supplemented on May
2, 2024 (ADAMS Accession No.
ML24123A242). The information
submitted by the applicant includes
certain administrative information
submitted pursuant to 10 CFR 50.33,
such as on financial qualifications;
technical information submitted
pursuant to 10 CFR 50.34; and the
environmental report submitted
pursuant to 10 CFR part 51,
‘‘Environmental Protection Regulations
for Domestic Licensing and Related
Regulatory Functions.’’ These notices
are being provided in accordance with
the requirements in 10 CFR 50.43(a)(3).
The NRC staff is currently
undertaking its acceptance review of the
application. If the application is
accepted for docketing, a subsequent
Federal Register notice will be issued
that addresses the acceptability of the
construction permit application for
docketing and provisions for
participation of the public in the
permitting process.
Dated: May 13, 2024.
For the Nuclear Regulatory Commission.
Mallecia A. Sutton,
Senior Project Manager, Advanced Reactor
Licensing Branch 1, Division of Advanced
Reactors and Non-Power Production and
Utilization Facilities, Office of Nuclear
Reactor Regulation.
[FR Doc. 2024–10729 Filed 6–3–24; 8:45 am]
BILLING CODE P
June 17, 2024 ...............
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on June 17, 2024 to discuss the
ACMUI’s subcommittee report on the
NRC staff’s proposed changes to NRC’s
requirements for medical use of
byproduct material to address reporting
of nuclear medicine injection
extravasations as medical events.
Meeting information, including a copy
of the agenda and handouts, will be
available on the ACMUI’s Meetings and
Related Documents web page at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2024.html
or by emailing Ms. L. Armstead at the
contact information below.
DATES: June 17, 2024, from 2:00 p.m. to
4:00 p.m. Eastern Time.
ADDRESSES: This is a virtual meeting.
SUMMARY:
Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZTQ4MWIwYjctYmFiYi00ZDJlLTgzZWUtMTEzZGUz
YThlMjA0%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2
c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d.
Meeting ID: 225 263 585 84.
Passcode: uGphXp.
Call in number (audio only): +301–576–2978, United States, Silver Spring.
Phone Conference ID: 558 124 30#.
Public Participation: The meeting will
be held using Microsoft Teams. Any
member of the public who wishes to
participate in the meeting via Microsoft
Teams or via phone can use the
information provided above or should
contact Ms. L. Armstead. Members of
the public should also monitor the
NRC’s Public Meeting Schedule at
https://www.nrc.gov/pmns/mtg for any
meeting updates.
FOR FURTHER INFORMATION CONTACT: Ms.
L. Armstead, email: lxa5@nrc.gov,
telephone: 301–415–1650.
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
NUCLEAR REGULATORY
COMMISSION
Webinar information
(Microsoft Teams)
Date
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar
will preside over the meeting. Dr. Jadvar
will conduct the meeting in a manner
that will facilitate the orderly conduct of
business. The following procedures
apply to public participation in the
meeting:
VerDate Sep<11>2014
48001
17:15 Jun 03, 2024
Jkt 262001
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. L. Armstead
using the contact information listed
above. All submittals must be received
by the close of business on June 11,
2024, and must only pertain to the
topics on the agenda.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chair.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2024.html on or about July 31, 2024.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. L.
Armstead of their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10 of
the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 29th day
of May, 2024.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2024–12103 Filed 6–3–24; 8:45 am]
BILLING CODE 7590–01–P
POSTAL REGULATORY COMMISSION
[Docket Nos. MC2024–324 and CP2024–332;
MC2024–325 and CP2024–333; MC2024–326
and CP2024–334; MC2024–327 and CP2024–
335; MC2024–328 and CP2024–336]
New Postal Products
AGENCY:
E:\FR\FM\04JNN1.SGM
Postal Regulatory Commission.
04JNN1
]]>Agencies
[Federal Register Volume 89, Number 108 (Tuesday, June 4, 2024)]
[Notices]
[Page 48001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12103]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on June 17, 2024 to discuss the ACMUI's subcommittee report on
the NRC staff's proposed changes to NRC's requirements for medical use
of byproduct material to address reporting of nuclear medicine
injection extravasations as medical events. Meeting information,
including a copy of the agenda and handouts, will be available on the
ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html or by emailing Ms.
L. Armstead at the contact information below.
DATES: June 17, 2024, from 2:00 p.m. to 4:00 p.m. Eastern Time.
ADDRESSES: This is a virtual meeting.
----------------------------------------------------------------------------------------------------------------
Date Webinar information (Microsoft Teams)
----------------------------------------------------------------------------------------------------------------
June 17, 2024............................... Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZTQ4MWIwYjctYmFiYi00ZDJlLTgzZWUtMTEzZGUzYThlMjA0%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%22304f46bf-32c2-4e0f-912c-878db895e74a%22%7d.
Meeting ID: 225 263 585 84.
Passcode: uGphXp.
Call in number (audio only): +301-576-2978, United States, Silver
Spring.
Phone Conference ID: 558 124 30#.
----------------------------------------------------------------------------------------------------------------
Public Participation: The meeting will be held using Microsoft
Teams. Any member of the public who wishes to participate in the
meeting via Microsoft Teams or via phone can use the information
provided above or should contact Ms. L. Armstead. Members of the public
should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates.
FOR FURTHER INFORMATION CONTACT: Ms. L. Armstead, email: [email protected],
telephone: 301-415-1650.
SUPPLEMENTARY INFORMATION:
Conduct of the Meeting
The ACMUI Chair, Dr. Hossein Jadvar will preside over the meeting.
Dr. Jadvar will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. L. Armstead using the contact information listed
above. All submittals must be received by the close of business on June
11, 2024, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about July 31, 2024.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. L. Armstead of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 29th day of May, 2024.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-12103 Filed 6-3-24; 8:45 am]
BILLING CODE 7590-01-P
